Marker Therapeutics Overview
Marker Therapeutics Discounted Cash Flow
DCF Analysis for MRKR.
Get informed when a big investor buys or sells
+ FollowFair Value
$1.05
Current Fair Value
$1.05
↓ 22.3% Downside
Overvalued by 22.3% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison